| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/31/2026 | ±1.9% | -2.2% | under-priced |
| 05/01/2026 | ±2.2% | -0.5% | over-priced |
| 02/12/2026 | ±3.0% | -3.0% | under-priced |
| 11/07/2025 | ±2.1% | +2.5% | under-priced |
| 08/01/2025 | ±2.4% | -2.1% | over-priced |
| 05/02/2025 | ±1.9% | +5.3% | under-priced |
| 02/20/2025 | ±1.8% | +1.6% | over-priced |
| 11/01/2024 | ±1.8% | -1.8% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $0.18 | $3M | $19M |
| Q1 FY2026 | $0.40 | $2M | $42M |
| Q4 FY2025 | — | $5M | $156M |
| Q3 FY2025 | $1.00 | $3M | $109M |
CPT (CPT) reports in 3 days, with the next report estimated for 10/30/2026. Across the last 8 reports, options priced an average ±2.1% earnings move while the stock actually moved 2.4% on average — the market has been roughly fair on CPT's earnings risk. Fundamentals into the print: EPS down 75.7% year-over-year, revenue up 18.9%. QuantLogix's live 5-factor engine currently reads CPT as a neutral at 48/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →